Asya Grinberg

Person

Lexington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
ALK7 binding proteins and uses thereof
- Patent number 12,365,736
- Issue date Jul 22, 2025
- Acceleron Pharma Inc.
- John Knopf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single-arm type I and type II receptor fusion proteins and uses the...
- Patent number 12,338,273
- Issue date Jun 24, 2025
- Accerelon Pharma Inc.
- Ravindra Kumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multi-specific binding proteins that bind HER2, NKG2D, and CD16, an...
- Patent number 12,275,791
- Issue date Apr 15, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 12,264,200
- Issue date Apr 1, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ALK4:actriib heteromultimers and uses thereof
- Patent number 12,258,380
- Issue date Mar 25, 2025
- Acceleron Pharma Inc.
- Ravindra Kumar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Variant ActRIIB proteins and uses thereof
- Patent number 12,240,887
- Issue date Mar 4, 2025
- Acceleron Pharma Inc.
- Ravindra Kumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multi-specific binding proteins that bind CD33, NKG2D, and CD16, an...
- Patent number 12,215,157
- Issue date Feb 4, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Proteins binding NKG2D, CD16 and CLEC12A
- Patent number 12,157,771
- Issue date Dec 3, 2024
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Twisted gastrulation polypeptides and uses thereof
- Patent number 12,145,970
- Issue date Nov 19, 2024
- Acceleron Pharma Inc.
- Rajasekhar Naga Venkata Sai Suragani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ALK1 receptor and ligand antagonists and uses thereof
- Patent number 12,144,860
- Issue date Nov 19, 2024
- Acceleron Pharma Inc.
- Asya Grinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 12,129,300
- Issue date Oct 29, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treatment of muscular dystrophy with ALK4:ActRIIB hetero...
- Patent number 12,054,753
- Issue date Aug 6, 2024
- Acceleron Pharma Inc.
- Ravindra Kumar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activin type 2 receptor binding proteins methods of making them
- Patent number 12,042,524
- Issue date Jul 23, 2024
- Acceleron Pharma Inc.
- Ravindra Kumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ALK7 antagonists and uses thereof
- Patent number 12,024,563
- Issue date Jul 2, 2024
- Acceleron Pharma Inc.
- John Knopf
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for treating pulmonary hypertension with a ligand binding d...
- Patent number 11,951,156
- Issue date Apr 9, 2024
- The Brigham & Women's Hospital, Inc.
- Paul B. Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 11,939,384
- Issue date Mar 26, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 11,884,733
- Issue date Jan 30, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-...
- Patent number 11,834,506
- Issue date Dec 5, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ALK7:ActRIIB heteromultimers and uses thereof
- Patent number 11,827,689
- Issue date Nov 28, 2023
- Acceleron Pharma Inc.
- Ravindra Kumar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Heterodimeric Fc-fused proteins
- Patent number 11,787,864
- Issue date Oct 17, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ALK7 binding proteins and uses thereof
- Patent number 11,708,414
- Issue date Jul 25, 2023
- Acceleron Pharma Inc.
- John Knopf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Endoglin peptides to treat fibrotic diseases
- Patent number 11,590,201
- Issue date Feb 28, 2023
- Acceleron Pharma, Inc.
- Asya Grinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treatment of Duchenne muscular dystrophy with follistat...
- Patent number 11,497,792
- Issue date Nov 15, 2022
- Acceleron Pharma Inc.
- Ravindra Kumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TGF-beta superfamily type I and type II receptor heteromultimers an...
- Patent number 11,440,949
- Issue date Sep 13, 2022
- Acceleron Pharma Inc.
- Ravindra Kumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ALK4:ActRIIB heteromultimers and uses thereof
- Patent number 11,279,746
- Issue date Mar 22, 2022
- Acceleron Pharma Inc.
- Ravindra Kumar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Variant ActRIIB proteins and uses thereof
- Patent number 11,267,865
- Issue date Mar 8, 2022
- Acceleron Pharma Inc.
- Ravindra Kumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single-arm type I and type II receptor fusion proteins and uses the...
- Patent number 11,208,460
- Issue date Dec 28, 2021
- Acceleron Pharma Inc.
- Ravindra Kumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ALK7 binding proteins and uses thereof
- Patent number 11,059,894
- Issue date Jul 13, 2021
- Acceleron Pharma Inc.
- John Knopf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ALK7:actriib heteromultimers and uses thereof
- Patent number 11,028,145
- Issue date Jun 8, 2021
- Acceleron Pharma Inc.
- Ravindra Kumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating a fibrotic disorder by administering transformi...
- Patent number 11,008,377
- Issue date May 18, 2021
- Acceleron Pharma Inc.
- Ravindra Kumar
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND HER2, NKG2D, AND CD16, AN...
- Publication number 20250206827
- Publication date Jun 26, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF
- Publication number 20250197469
- Publication date Jun 19, 2025
- Acceleron Pharma Inc.
- Ravindra Kumar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...
- Publication number 20250154261
- Publication date May 15, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF
- Publication number 20250084388
- Publication date Mar 13, 2025
- Acceleron Pharma Inc.
- Ravindra Kumar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ACTRIIB BINDING AGENTS AND USES THEREOF
- Publication number 20250066488
- Publication date Feb 27, 2025
- Acceleron Pharma Inc.
- Ravindra Kumar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20250019444
- Publication date Jan 16, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Activin Type 2 Receptor Binding Proteins and Methods of Making Them
- Publication number 20240374671
- Publication date Nov 14, 2024
- Acceleron Pharma Inc.
- Ravindra Kumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION
- Publication number 20240366720
- Publication date Nov 7, 2024
- The Brigham & Women's Hospital, Inc.
- Paul B. YU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND BAFF-R
- Publication number 20240360223
- Publication date Oct 31, 2024
- Dragonfly Therapeutics, Inc.
- Aaron BELLI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALK7 ANTAGONISTS AND USES THEREOF
- Publication number 20240309098
- Publication date Sep 19, 2024
- Acceleron Pharma Inc.
- John Knopf
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND BAFF-R
- Publication number 20240270861
- Publication date Aug 15, 2024
- Dragonfly Therapeutics, Inc.
- Aaron BELLI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING FLT3 AND USE THEREOF
- Publication number 20240228628
- Publication date Jul 11, 2024
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND NKG2D, CD16, AND A TUMOR-...
- Publication number 20240166753
- Publication date May 23, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AN...
- Publication number 20240158468
- Publication date May 16, 2024
- Acceleron Pharma Inc.
- Ravindra Kumar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES TARGETING FLT3 AND USE THEREOF
- Publication number 20240132598
- Publication date Apr 25, 2024
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16, AND CEACAM5
- Publication number 20240124607
- Publication date Apr 18, 2024
- Merck Sharp & Dohme LLC
- Amy M. Beebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND FLT3
- Publication number 20240117054
- Publication date Apr 11, 2024
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240076385
- Publication date Mar 7, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240076384
- Publication date Mar 7, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240067735
- Publication date Feb 29, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALK7 Binding Proteins and Uses Thereof
- Publication number 20230416379
- Publication date Dec 28, 2023
- Acceleron Pharma, Inc.
- John Knopf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND NECTIN4
- Publication number 20230357409
- Publication date Nov 9, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20230303702
- Publication date Sep 28, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING EGFR AND USE THEREOF
- Publication number 20230279121
- Publication date Sep 7, 2023
- Dragonfly Therapeutics, Inc.
- Asya Grinberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Formulation, Dosage Regimen, and Manufacturing Process for Heterodi...
- Publication number 20230272041
- Publication date Aug 31, 2023
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AN...
- Publication number 20230265161
- Publication date Aug 24, 2023
- Acceleron Pharma Inc.
- Ravindra Kumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND EGFR
- Publication number 20230257467
- Publication date Aug 17, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PPHARMACEUTICAL FORMULATIONS AND THERAPEUTIC USES OF MULTI-SPECIFIC...
- Publication number 20230250176
- Publication date Aug 10, 2023
- Dragonfly Therapeutics, Inc.
- Ann F. Cheung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TWISTED GASTRULATION POLYPEPTIDES AND USES THEREOF
- Publication number 20230234998
- Publication date Jul 27, 2023
- Acceleron Pharma Inc.
- RAJASEKHAR NAGA VENKATA SAI SURAGANI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20230227562
- Publication date Jul 20, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Asya Grinberg

Person

Patents Grantslast 30 patents

ALK7 binding proteins and uses thereof

Single-arm type I and type II receptor fusion proteins and uses the...

Multi-specific binding proteins that bind HER2, NKG2D, and CD16, an...

Antibody variable domains targeting the NKG2D receptor

ALK4:actriib heteromultimers and uses thereof

Variant ActRIIB proteins and uses thereof

Multi-specific binding proteins that bind CD33, NKG2D, and CD16, an...

Proteins binding NKG2D, CD16 and CLEC12A

Twisted gastrulation polypeptides and uses thereof

ALK1 receptor and ligand antagonists and uses thereof

Antibody variable domains targeting the NKG2D receptor

Methods of treatment of muscular dystrophy with ALK4:ActRIIB hetero...

Activin type 2 receptor binding proteins methods of making them

ALK7 antagonists and uses thereof

Methods for treating pulmonary hypertension with a ligand binding d...

Antibody variable domains targeting the NKG2D receptor

Antibody variable domains targeting the NKG2D receptor

Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-...

ALK7:ActRIIB heteromultimers and uses thereof

Heterodimeric Fc-fused proteins

ALK7 binding proteins and uses thereof

Endoglin peptides to treat fibrotic diseases

Methods for treatment of Duchenne muscular dystrophy with follistat...

TGF-beta superfamily type I and type II receptor heteromultimers an...

ALK4:ActRIIB heteromultimers and uses thereof

Variant ActRIIB proteins and uses thereof

Single-arm type I and type II receptor fusion proteins and uses the...

ALK7 binding proteins and uses thereof

ALK7:actriib heteromultimers and uses thereof

Methods of treating a fibrotic disorder by administering transformi...

Patents Applicationslast 30 patents

MULTI-SPECIFIC BINDING PROTEINS THAT BIND HER2, NKG2D, AND CD16, AN...

ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF

MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...

ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF

ACTRIIB BINDING AGENTS AND USES THEREOF

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

Activin Type 2 Receptor Binding Proteins and Methods of Making Them

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

PROTEINS BINDING NKG2D, CD16 AND BAFF-R

ALK7 ANTAGONISTS AND USES THEREOF

PROTEINS BINDING NKG2D, CD16 AND BAFF-R

ANTIBODIES TARGETING FLT3 AND USE THEREOF

MULTI-SPECIFIC BINDING PROTEINS THAT BIND NKG2D, CD16, AND A TUMOR-...

TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AN...

ANTIBODIES TARGETING FLT3 AND USE THEREOF

PROTEINS BINDING NKG2D, CD16, AND CEACAM5

PROTEINS BINDING NKG2D, CD16 AND FLT3

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

ALK7 Binding Proteins and Uses Thereof

PROTEINS BINDING NKG2D, CD16 AND NECTIN4

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...

ANTIBODIES TARGETING EGFR AND USE THEREOF

Formulation, Dosage Regimen, and Manufacturing Process for Heterodi...

TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AN...

PROTEINS BINDING NKG2D, CD16 AND EGFR

PPHARMACEUTICAL FORMULATIONS AND THERAPEUTIC USES OF MULTI-SPECIFIC...

TWISTED GASTRULATION POLYPEPTIDES AND USES THEREOF

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...